---
layout: post
title: "Determination That MPI DMSA KIDNEY REAGENT (Technetium Tc-99m Succimer Kit), Injectable, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness"
date: 2026-02-05 18:58:27 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-05324
original_published: 2022-03-14 00:00:00 +0000
significance: 8.00
---

# Determination That MPI DMSA KIDNEY REAGENT (Technetium Tc-99m Succimer Kit), Injectable, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness

**Published:** February 05, 2026 18:58 UTC
**Source:** Federal Register
**Original Published:** March 14, 2022 00:00 UTC
**Document Number:** 2022-05324

## Summary

The Food and Drug Administration (FDA, Agency, or we) has determined that MPI DMSA KIDNEY REAGENT (Technetium Tc-99m Succimer Kit), Injectable, was not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve abbreviated new drug applications (ANDAs) for Technetium Tc-99m Succimer Kit, Injectable, if all other legal and regulatory requirements are met.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/03/14/2022-05324/determination-that-mpi-dmsa-kidney-reagent-technetium-tc-99m-succimer-kit-injectable-was-not)
- API: https://www.federalregister.gov/api/v1/documents/2022-05324

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
